NGNE
Neurogene Inc
NASDAQ: NGNE · HEALTHCARE · BIOTECHNOLOGY
$26.48
-3.53% today
Updated 2026-04-29
Market cap
$422.41M
P/E ratio
—
P/S ratio
438.73x
EPS (TTM)
$-4.24
Dividend yield
—
52W range
$12 – $37
Volume
0.2M
Neurogene Inc (NGNE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |